|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Synthesis and anti-inflammatory activity of novel pyridazine and pyridazinone deriva- tives as non-ulcerogenic agents显示文摘 | Makarem M Saeed Nadia A Khalil Eman M | 2012 | Arch Pharm Res2012，35，12： | 1 |
| 2 | Errect or y''st (Saccharomyces cerevisiae) on Reduct ion or A r-laroxicosis, Enhancement or Growth Performance and Expres-sion or Neural and Gonadal Genes in Japanese Quail显示文摘 | Mariam G Eshak Wagdy K B Khalil Eman M Hegazy | | Jour-nal or American Science0，6，12： | 1 |
| 3 | Biosynthesis of Au Nanoparticles Using Olive Leaf Extract 显示文摘 | MOSTAFA M H KHALIL EMAN H ISMAIL FATMA EL-MAGDOUB | 2010 | Arabian Journal of Chemistry2010，11，11： | 1 |
| 4 | 氨三乙酸、缬氨酸、亮氨酸的三元过渡金属配合物:合成和生物学应用(英文)显示文摘以氨三乙酸HNTA2-为主要配体,缬氨酸(valine)或亮氨酸(leucine)为次要配体在微酸性介质中合成了Ni(Ⅱ),Cu(Ⅱ),and Zn(Ⅱ)的三元配合物。用元素分析、热分析、FTIR,UV-Vis分光光度法,磁性测量和质谱法表征了合成的三元配合物。结果表明,三元配合物可在金属(M):氨三乙酸(HNTA)∶缬氨酸(valine)或亮氨酸(leucine)=1∶1∶1时制得,其分子结构为[M(HNTA)(valine)(H2O)2].1.5H2O and[M(HNTA)(leucine)(H2O)2].1.5H2O(其中M=Ni(Ⅱ)or Cu(Ⅱ))和H2[Zn(NTA)(valine)(H2O)]H2O。标题三元过渡金属配合物为八面体对称构型。同时研究了该三元配合物对大肠杆菌,金黄色葡萄球菌,白色念珠菌,黄曲霉菌(菌株从开罗大学理学院微分析中心获得)的抗菌活性。根据推荐的知名方法用标准的抗菌和抗真菌剂进行体外测试(in vitro)以评估我们的新制备的配合物对细菌和真菌物种的生长抑制活性。 | Mostafa M H Khalil Eglal R Souaya Eman H Ismail Eman Rabie | 2013 | 无机化学学报2013，29，9： | 0 |
| 5 | Cardiac stem cells: Current knowledge and future prospects显示文摘Regenerative medicine is the field concerned with the repair and restoration of the integrity of damaged human tissues as well as whole organs.Since the inception of the field several decades ago,regenerative medicine therapies,namely stem cells,have received significant attention in preclinical studies and clinical trials.Apart from their known potential for differentiation into the various body cells,stem cells enhance the organ's intrinsic regenerative capacity by altering its environment,whether by exogenous injection or introducing their products that modulate endogenous stem cell function and fate for the sake of regeneration.Recently,research in cardiology has highlighted the evidence for the existence of cardiac stem and progenitor cells(CSCs/CPCs).The global burden of cardiovascular diseases’morbidity and mortality has demanded an in-depth understanding of the biology of CSCs/CPCs aiming at improving the outcome for an innovative therapeutic strategy.This review will discuss the nature of each of the CSCs/CPCs,their environment,their interplay with other cells,and their metabolism.In addition,important issues are tackled concerning the potency of CSCs/CPCs in relation to their secretome for mediating the ability to influence other cells.Moreover,the review will throw the light on the clinical trials and the preclinical studies using CSCs/CPCs and combined therapy for cardiac regeneration.Finally,the novel role of nanotechnology in cardiac regeneration will be explored. | Radwa A Mehanna Marwa M Essawy Mona A Barkat Ashraf K Awaad Eman H Thabet Heba A Hamed Hagar Elkafrawy Nehal A Khalil Abeer Sallam Marwa A Kholief Samar S Ibrahim Ghada M Mourad | 2022 | World Journal of Stem Cells2022，14，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员